| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:517225818:1799 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:517225818:1799?format=raw |
LEADER: 01799cam a2200409 a 4500
001 3960167
005 20221027010350.0
008 910919s1991 maua b 001 0 eng c
010 $a 91007026
020 $a0792312120
035 $a(OCoLC)23287814
035 $a(OCoLC)ocm23287814
035 $a(CStRLIN)NYCM91-B5345
035 $9AFS0561HS
035 $a(NNC)3960167
035 $a3960167
040 $aDNLM/DLC$cDLC$dNNC-M
050 00 $aRC271.C5$bM644 1991
060 0 $aW1 CA693 v. 57$aQZ 267 M7184
082 00 $a616.99/4061$220
245 00 $aMolecular and clinical advances in anticancer drug resistance /$cedited by Robert F. Ozols.
260 $aBoston :$bKluwer Academic Publishers,$c1991.
300 $axii, 308 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCancer treatment and research ;$v57
504 $aIncludes bibliographical references and index.
650 0 $aDrug resistance in cancer cells.$0http://id.loc.gov/authorities/subjects/sh90005205
650 2 $aAlkylating Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000477Q000494
650 2 $aDoxorubicin$xpharmacology.$0https://id.nlm.nih.gov/mesh/D004317Q000494
650 2 $aDrug Resistance$xgenetics.$0https://id.nlm.nih.gov/mesh/D004351Q000235
650 2 $aMembrane Glycoproteins$xgenetics.$0https://id.nlm.nih.gov/mesh/D008562Q000235
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
650 2 $aVinblastine$xpharmacology.$0https://id.nlm.nih.gov/mesh/D014747Q000494
700 1 $aOzols, Robert F.$0http://id.loc.gov/authorities/names/n86108611
830 0 $aCancer treatment and research ;$vv. 57.$0http://id.loc.gov/authorities/names/n42005764
852 00 $boff,hsl$hRC271.C5$iM644 1991